Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 6.96970846 |
2 | ensheathment of neurons (GO:0007272) | 6.37034329 |
3 | axon ensheathment (GO:0008366) | 6.37034329 |
4 | myelination (GO:0042552) | 6.28027770 |
5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.08274908 |
6 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.33066703 |
7 | negative regulation of neurotransmitter transport (GO:0051589) | 5.00996770 |
8 | myelin maintenance (GO:0043217) | 4.73232004 |
9 | response to interferon-beta (GO:0035456) | 4.57194487 |
10 | type I interferon signaling pathway (GO:0060337) | 4.54266301 |
11 | cellular response to type I interferon (GO:0071357) | 4.54266301 |
12 | regulation of collateral sprouting (GO:0048670) | 4.49283006 |
13 | response to type I interferon (GO:0034340) | 4.48533922 |
14 | response to interferon-alpha (GO:0035455) | 4.48395278 |
15 | negative regulation of viral genome replication (GO:0045071) | 4.44789391 |
16 | oligodendrocyte differentiation (GO:0048709) | 4.40176369 |
17 | cholesterol biosynthetic process (GO:0006695) | 4.22863194 |
18 | L-amino acid import (GO:0043092) | 4.22241029 |
19 | neutrophil activation involved in immune response (GO:0002283) | 4.21800730 |
20 | regulation of interferon-alpha production (GO:0032647) | 4.19910561 |
21 | import into cell (GO:0098657) | 4.17612129 |
22 | response to methylmercury (GO:0051597) | 4.13361972 |
23 | negative regulation of protein localization to cell surface (GO:2000009) | 4.10035346 |
24 | presynaptic membrane organization (GO:0097090) | 4.09507737 |
25 | positive regulation of interferon-alpha production (GO:0032727) | 4.09380085 |
26 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.06415658 |
27 | isoprenoid biosynthetic process (GO:0008299) | 4.01070194 |
28 | limb bud formation (GO:0060174) | 4.00227737 |
29 | creatine metabolic process (GO:0006600) | 3.93161304 |
30 | glycerophospholipid catabolic process (GO:0046475) | 3.91342260 |
31 | presynaptic membrane assembly (GO:0097105) | 3.83793459 |
32 | photoreceptor cell differentiation (GO:0046530) | 3.77584720 |
33 | eye photoreceptor cell differentiation (GO:0001754) | 3.77584720 |
34 | establishment of mitochondrion localization (GO:0051654) | 3.76573933 |
35 | sterol biosynthetic process (GO:0016126) | 3.70000804 |
36 | neuron remodeling (GO:0016322) | 3.67109048 |
37 | cellular response to interferon-alpha (GO:0035457) | 3.53891454 |
38 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.52355963 |
39 | amyloid precursor protein metabolic process (GO:0042982) | 3.52007573 |
40 | astrocyte development (GO:0014002) | 3.51774781 |
41 | rRNA catabolic process (GO:0016075) | 3.46760088 |
42 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.46165324 |
43 | asymmetric protein localization (GO:0008105) | 3.45629804 |
44 | platelet dense granule organization (GO:0060155) | 3.43732013 |
45 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.42047083 |
46 | organ growth (GO:0035265) | 3.41549345 |
47 | response to lipoprotein particle (GO:0055094) | 3.37046051 |
48 | protein palmitoylation (GO:0018345) | 3.34731876 |
49 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.33952527 |
50 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.32496160 |
51 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30871457 |
52 | GPI anchor biosynthetic process (GO:0006506) | 3.30835110 |
53 | DNA deamination (GO:0045006) | 3.29691639 |
54 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.29427141 |
55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29273194 |
56 | apical protein localization (GO:0045176) | 3.26483001 |
57 | * negative regulation of viral process (GO:0048525) | 3.24565275 |
58 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.24416785 |
59 | substantia nigra development (GO:0021762) | 3.24003249 |
60 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.22019405 |
61 | sphingosine metabolic process (GO:0006670) | 3.21732289 |
62 | cellular response to interferon-beta (GO:0035458) | 3.21619684 |
63 | GPI anchor metabolic process (GO:0006505) | 3.16853843 |
64 | positive regulation of interferon-beta production (GO:0032728) | 3.14768018 |
65 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.12907038 |
66 | regulation of viral genome replication (GO:0045069) | 3.12306424 |
67 | macrophage activation involved in immune response (GO:0002281) | 3.11182274 |
68 | response to redox state (GO:0051775) | 3.10921787 |
69 | replicative senescence (GO:0090399) | 3.10682795 |
70 | indole-containing compound catabolic process (GO:0042436) | 3.08306610 |
71 | indolalkylamine catabolic process (GO:0046218) | 3.08306610 |
72 | tryptophan catabolic process (GO:0006569) | 3.08306610 |
73 | regulation of interleukin-8 secretion (GO:2000482) | 3.07858802 |
74 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.05995263 |
75 | neuron cell-cell adhesion (GO:0007158) | 3.03506117 |
76 | magnesium ion transport (GO:0015693) | 3.03487492 |
77 | amino acid import (GO:0043090) | 3.03109493 |
78 | immunoglobulin mediated immune response (GO:0016064) | 3.02136459 |
79 | response to nitrosative stress (GO:0051409) | 3.01604548 |
80 | regulation of lipoprotein metabolic process (GO:0050746) | 3.01120881 |
81 | * defense response to virus (GO:0051607) | 2.98583513 |
82 | tryptophan metabolic process (GO:0006568) | 2.96843806 |
83 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.96608605 |
84 | positive regulation of action potential (GO:0045760) | 2.95974944 |
85 | * negative regulation of viral entry into host cell (GO:0046597) | 2.94368053 |
86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.93434467 |
87 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.93121011 |
88 | cellular response to epinephrine stimulus (GO:0071872) | 2.90978472 |
89 | regulation of RIG-I signaling pathway (GO:0039535) | 2.90586682 |
90 | nucleotide transmembrane transport (GO:1901679) | 2.90428029 |
91 | histone H2B ubiquitination (GO:0033523) | 2.89403170 |
92 | cellular response to exogenous dsRNA (GO:0071360) | 2.85305753 |
93 | adult walking behavior (GO:0007628) | 2.84952058 |
94 | axon development (GO:0061564) | 2.83629096 |
95 | membrane tubulation (GO:0097320) | 2.82213373 |
96 | B cell mediated immunity (GO:0019724) | 2.80416815 |
97 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.79097734 |
98 | adhesion of symbiont to host cell (GO:0044650) | 2.76975791 |
99 | virion attachment to host cell (GO:0019062) | 2.76975791 |
100 | regulation of pigment cell differentiation (GO:0050932) | 2.75701005 |
101 | positive regulation of glial cell differentiation (GO:0045687) | 2.75483602 |
102 | myelination in peripheral nervous system (GO:0022011) | 2.75427062 |
103 | peripheral nervous system axon ensheathment (GO:0032292) | 2.75427062 |
104 | kynurenine metabolic process (GO:0070189) | 2.73732507 |
105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.73192342 |
106 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.72024814 |
107 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.72024814 |
108 | negative regulation of axonogenesis (GO:0050771) | 2.71820804 |
109 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.71636577 |
110 | lateral sprouting from an epithelium (GO:0060601) | 2.70858832 |
111 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.70724269 |
112 | DNA strand renaturation (GO:0000733) | 2.68924322 |
113 | cranial nerve development (GO:0021545) | 2.67063431 |
114 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.66421044 |
115 | indolalkylamine metabolic process (GO:0006586) | 2.65885075 |
116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65479218 |
117 | amyloid precursor protein catabolic process (GO:0042987) | 2.65380557 |
118 | proteasome assembly (GO:0043248) | 2.63138428 |
119 | regulation of somitogenesis (GO:0014807) | 2.62759026 |
120 | very long-chain fatty acid metabolic process (GO:0000038) | 2.62654779 |
121 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.62151038 |
122 | transmission of nerve impulse (GO:0019226) | 2.62078167 |
123 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.60230501 |
124 | regulation of thymocyte apoptotic process (GO:0070243) | 2.60202982 |
125 | enteric nervous system development (GO:0048484) | 2.59967238 |
126 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.59583404 |
127 | artery development (GO:0060840) | 2.58940576 |
128 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.58823403 |
129 | * regulation of viral entry into host cell (GO:0046596) | 2.58805171 |
130 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.58317055 |
131 | glial cell development (GO:0021782) | 2.57659422 |
132 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.57469810 |
133 | sphingoid metabolic process (GO:0046519) | 2.56778680 |
134 | negative regulation of axon extension (GO:0030517) | 2.56733092 |
135 | neurotransmitter uptake (GO:0001504) | 2.56591121 |
136 | response to xenobiotic stimulus (GO:0009410) | 2.54989521 |
137 | positive regulation of gliogenesis (GO:0014015) | 2.54751379 |
138 | polyol transport (GO:0015791) | 2.54320105 |
139 | glial cell differentiation (GO:0010001) | 2.54249646 |
140 | response to epinephrine (GO:0071871) | 2.53616397 |
141 | negative regulation of exocytosis (GO:0045920) | 2.53462916 |
142 | regulation of interleukin-13 production (GO:0032656) | 2.52780381 |
143 | neuronal action potential propagation (GO:0019227) | 2.51429456 |
144 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.51199924 |
145 | diol metabolic process (GO:0034311) | 2.50361794 |
146 | dopamine biosynthetic process (GO:0042416) | 2.48611228 |
147 | positive regulation of interleukin-17 production (GO:0032740) | 2.48501667 |
148 | cyclic nucleotide catabolic process (GO:0009214) | 2.48449256 |
149 | double-strand break repair via homologous recombination (GO:0000724) | 2.47792620 |
150 | regulation of T-helper 1 type immune response (GO:0002825) | 2.46247992 |
151 | neuronal ion channel clustering (GO:0045161) | 2.45987622 |
152 | neutrophil activation (GO:0042119) | 2.45005806 |
153 | recombinational repair (GO:0000725) | 2.44173928 |
154 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.43700930 |
155 | replication fork processing (GO:0031297) | 2.43302786 |
156 | response to protozoan (GO:0001562) | 2.43240960 |
157 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.42450871 |
158 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.42450871 |
159 | isotype switching (GO:0045190) | 2.42450871 |
160 | positive regulation of T cell apoptotic process (GO:0070234) | 2.41099279 |
161 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.39861087 |
162 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.39800298 |
163 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.39800298 |
164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39709901 |
165 | modulation by symbiont of host defense response (GO:0052031) | 2.39709901 |
166 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39709901 |
167 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39709901 |
168 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39709901 |
169 | modulation by symbiont of host immune response (GO:0052553) | 2.39709901 |
170 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.39642449 |
171 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38864756 |
172 | cytidine catabolic process (GO:0006216) | 2.38052843 |
173 | cytidine deamination (GO:0009972) | 2.38052843 |
174 | cytidine metabolic process (GO:0046087) | 2.38052843 |
175 | short-term memory (GO:0007614) | 2.37554237 |
176 | negative regulation of interleukin-10 production (GO:0032693) | 2.37249356 |
177 | regulation of antigen processing and presentation (GO:0002577) | 2.37084009 |
178 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.36729583 |
179 | regulation of interferon-beta production (GO:0032648) | 2.36574610 |
180 | glycosylceramide metabolic process (GO:0006677) | 2.36089759 |
181 | retina layer formation (GO:0010842) | 2.36059383 |
182 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.36055364 |
183 | microtubule polymerization or depolymerization (GO:0031109) | 2.35796812 |
184 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.35095467 |
185 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33471884 |
186 | negative regulation of viral transcription (GO:0032897) | 2.30929046 |
187 | positive regulation of defense response to virus by host (GO:0002230) | 2.27982963 |
188 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.27019703 |
189 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.26730937 |
190 | defense response to protozoan (GO:0042832) | 2.26476838 |
191 | granulocyte activation (GO:0036230) | 2.26166378 |
192 | regulation of meiosis I (GO:0060631) | 2.25459425 |
193 | regulation of defense response to virus by host (GO:0050691) | 2.25073499 |
194 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.24571296 |
195 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.23164506 |
196 | natural killer cell activation involved in immune response (GO:0002323) | 2.22798423 |
197 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.21961102 |
198 | axon ensheathment in central nervous system (GO:0032291) | 11.3013860 |
199 | central nervous system myelination (GO:0022010) | 11.3013860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25034389 |
2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.43300908 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12939297 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95855114 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95105650 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.71971649 |
7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.67324404 |
8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.55281909 |
9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54416656 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47558093 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41921199 |
12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.37656848 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37399314 |
14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.31533434 |
15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30451620 |
16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.26632418 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20397685 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20039821 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12921729 |
20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.12582866 |
21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10167596 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07968246 |
23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.07816130 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07410052 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07410052 |
26 | EWS_26573619_Chip-Seq_HEK293_Human | 2.01166611 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99876559 |
28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98517313 |
29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94897693 |
30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88565685 |
31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.88086574 |
32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82524354 |
33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82151751 |
34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81308086 |
35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77274285 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77197421 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77105252 |
38 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75531151 |
39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.75368859 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74900809 |
41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73879690 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72358031 |
43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.72004465 |
44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71751990 |
45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70243466 |
46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67425206 |
47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67182077 |
48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62329347 |
49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61519216 |
50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60405878 |
51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.58576204 |
52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53880202 |
53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52987678 |
54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52895842 |
55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52437319 |
56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.52308735 |
57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51980123 |
58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48542383 |
59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46738710 |
60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46296437 |
61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.43178779 |
62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42217936 |
63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42058449 |
64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41748708 |
65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41747166 |
66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39260786 |
67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39233507 |
68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37223493 |
69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37036287 |
70 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36549858 |
71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35915567 |
72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34913262 |
73 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.34521556 |
74 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34484553 |
75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34481064 |
76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33889916 |
77 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.33794587 |
78 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.33156532 |
79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32596594 |
80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32233767 |
81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32057328 |
82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31444276 |
83 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30800864 |
84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30672398 |
85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28441303 |
86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27959202 |
87 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27872102 |
88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27839150 |
89 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.27609135 |
90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26910117 |
91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24965421 |
92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24327916 |
93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22817393 |
94 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22433357 |
95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.22337923 |
96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22208172 |
97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21884019 |
98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21491122 |
99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21320204 |
100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.20718709 |
101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20683630 |
102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20642309 |
103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20053613 |
104 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19639727 |
105 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19639727 |
106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18458318 |
107 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17829233 |
108 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17677302 |
109 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16815709 |
110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16706510 |
111 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.16314490 |
112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15664229 |
113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15532051 |
114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15357863 |
115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14851323 |
116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14806301 |
117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14135964 |
118 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13702568 |
119 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12833853 |
120 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10246287 |
121 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10246287 |
122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08950925 |
123 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08403364 |
124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07940988 |
125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07881481 |
126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07433713 |
127 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.07373105 |
128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07025771 |
129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06719798 |
130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04621481 |
131 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04590557 |
132 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04585743 |
133 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04472324 |
134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03938632 |
135 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03035278 |
136 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02731351 |
137 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02676625 |
138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02506511 |
139 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02392627 |
140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01934592 |
141 | MYB_26560356_Chip-Seq_TH2_Human | 1.01010671 |
142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00619796 |
143 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00588790 |
144 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00446368 |
145 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00431810 |
146 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99925556 |
147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99620477 |
148 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99415118 |
149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99292131 |
150 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.98871522 |
151 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98739777 |
152 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98739777 |
153 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98207255 |
154 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98207255 |
155 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97668615 |
156 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96997409 |
157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96616601 |
158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96523073 |
159 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95086151 |
160 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95044620 |
161 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94891792 |
162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93821299 |
163 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93449637 |
164 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92857091 |
165 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92699631 |
166 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91726906 |
167 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91459933 |
168 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89646733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0006054_spinal_hemorrhage | 7.22440949 |
2 | MP0000920_abnormal_myelination | 5.07504266 |
3 | MP0003136_yellow_coat_color | 4.14846585 |
4 | MP0003880_abnormal_central_pattern | 3.57617479 |
5 | MP0002138_abnormal_hepatobiliary_system | 3.45693247 |
6 | MP0009697_abnormal_copulation | 3.43539443 |
7 | MP0005409_darkened_coat_color | 3.26695175 |
8 | MP0004381_abnormal_hair_follicle | 3.19190408 |
9 | MP0003950_abnormal_plasma_membrane | 3.10773484 |
10 | MP0001835_abnormal_antigen_presentation | 3.00197298 |
11 | MP0004742_abnormal_vestibular_system | 2.80231349 |
12 | MP0005171_absent_coat_pigmentation | 2.74104900 |
13 | MP0009785_altered_susceptibility_to | 2.67819507 |
14 | MP0003690_abnormal_glial_cell | 2.60550143 |
15 | MP0008260_abnormal_autophagy | 2.44631758 |
16 | MP0004270_analgesia | 2.42745130 |
17 | MP0001486_abnormal_startle_reflex | 2.39024269 |
18 | MP0004885_abnormal_endolymph | 2.35935792 |
19 | MP0001905_abnormal_dopamine_level | 2.31965772 |
20 | MP0002254_reproductive_system_inflammat | 2.26244984 |
21 | MP0002148_abnormal_hypersensitivity_rea | 2.19661240 |
22 | MP0002272_abnormal_nervous_system | 2.18488961 |
23 | MP0000685_abnormal_immune_system | 2.16707296 |
24 | MP0001529_abnormal_vocalization | 2.11879283 |
25 | MP0004142_abnormal_muscle_tone | 2.05839569 |
26 | MP0002102_abnormal_ear_morphology | 2.02346550 |
27 | MP0005451_abnormal_body_composition | 1.91789661 |
28 | MP0005084_abnormal_gallbladder_morpholo | 1.90409176 |
29 | MP0003634_abnormal_glial_cell | 1.89731917 |
30 | MP0005423_abnormal_somatic_nervous | 1.87549383 |
31 | MP0001661_extended_life_span | 1.86501643 |
32 | MP0001485_abnormal_pinna_reflex | 1.85684619 |
33 | MP0009764_decreased_sensitivity_to | 1.83437035 |
34 | MP0000383_abnormal_hair_follicle | 1.80239864 |
35 | MP0002064_seizures | 1.78832170 |
36 | MP0000569_abnormal_digit_pigmentation | 1.78782653 |
37 | MP0003329_amyloid_beta_deposits | 1.78207749 |
38 | MP0000778_abnormal_nervous_system | 1.78131501 |
39 | MP0004134_abnormal_chest_morphology | 1.74114520 |
40 | MP0000566_synostosis | 1.72515680 |
41 | MP0010678_abnormal_skin_adnexa | 1.67788053 |
42 | MP0002229_neurodegeneration | 1.65079491 |
43 | MP0005671_abnormal_response_to | 1.64738240 |
44 | MP0001800_abnormal_humoral_immune | 1.64075857 |
45 | MP0003252_abnormal_bile_duct | 1.58808483 |
46 | MP0003303_peritoneal_inflammation | 1.58758640 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.58497304 |
48 | MP0002452_abnormal_antigen_presenting | 1.57540632 |
49 | MP0000372_irregular_coat_pigmentation | 1.56677310 |
50 | MP0005410_abnormal_fertilization | 1.56389848 |
51 | MP0001188_hyperpigmentation | 1.52613140 |
52 | MP0009046_muscle_twitch | 1.51444454 |
53 | MP0002723_abnormal_immune_serum | 1.51282533 |
54 | MP0009745_abnormal_behavioral_response | 1.51163085 |
55 | MP0005000_abnormal_immune_tolerance | 1.50080130 |
56 | MP0000462_abnormal_digestive_system | 1.49664332 |
57 | MP0005025_abnormal_response_to | 1.47293321 |
58 | MP0003436_decreased_susceptibility_to | 1.46064495 |
59 | MP0001963_abnormal_hearing_physiology | 1.44689942 |
60 | MP0005551_abnormal_eye_electrophysiolog | 1.42154726 |
61 | MP0002419_abnormal_innate_immunity | 1.41795095 |
62 | MP0004272_abnormal_basement_membrane | 1.39988985 |
63 | MP0003632_abnormal_nervous_system | 1.37083357 |
64 | MP0003300_gastrointestinal_ulcer | 1.33785491 |
65 | MP0002168_other_aberrant_phenotype | 1.30438621 |
66 | MP0003938_abnormal_ear_development | 1.28878226 |
67 | MP0001440_abnormal_grooming_behavior | 1.25752784 |
68 | MP0002734_abnormal_mechanical_nocicepti | 1.25641605 |
69 | MP0008877_abnormal_DNA_methylation | 1.25499914 |
70 | MP0001346_abnormal_lacrimal_gland | 1.22889870 |
71 | MP0001851_eye_inflammation | 1.22269227 |
72 | MP0002396_abnormal_hematopoietic_system | 1.22202185 |
73 | MP0003635_abnormal_synaptic_transmissio | 1.21158289 |
74 | MP0004859_abnormal_synaptic_plasticity | 1.20760522 |
75 | MP0003186_abnormal_redox_activity | 1.20056092 |
76 | MP0004147_increased_porphyrin_level | 1.19013049 |
77 | MP0005248_abnormal_Harderian_gland | 1.18633078 |
78 | MP0001819_abnormal_immune_cell | 1.18207418 |
79 | MP0010368_abnormal_lymphatic_system | 1.18149986 |
80 | MP0002420_abnormal_adaptive_immunity | 1.17545180 |
81 | MP0001915_intracranial_hemorrhage | 1.17239296 |
82 | MP0000026_abnormal_inner_ear | 1.17074522 |
83 | MP0002006_tumorigenesis | 1.16913798 |
84 | MP0000762_abnormal_tongue_morphology | 1.15505754 |
85 | MP0001986_abnormal_taste_sensitivity | 1.14103729 |
86 | MP0002752_abnormal_somatic_nervous | 1.13294602 |
87 | MP0005167_abnormal_blood-brain_barrier | 1.13122821 |
88 | MP0003631_nervous_system_phenotype | 1.12623837 |
89 | MP0001970_abnormal_pain_threshold | 1.12145181 |
90 | MP0002282_abnormal_trachea_morphology | 1.10132476 |
91 | MP0002572_abnormal_emotion/affect_behav | 1.09897139 |
92 | MP0002882_abnormal_neuron_morphology | 1.09527429 |
93 | MP0002067_abnormal_sensory_capabilities | 1.08784226 |
94 | MP0001845_abnormal_inflammatory_respons | 1.07460766 |
95 | MP0008569_lethality_at_weaning | 1.06594151 |
96 | MP0005174_abnormal_tail_pigmentation | 1.05699486 |
97 | MP0006082_CNS_inflammation | 1.05511971 |
98 | MP0003448_altered_tumor_morphology | 1.04396463 |
99 | MP0008469_abnormal_protein_level | 1.04396076 |
100 | MP0001293_anophthalmia | 1.03419151 |
101 | MP0005395_other_phenotype | 1.03064732 |
102 | MP0000465_gastrointestinal_hemorrhage | 1.01717033 |
103 | MP0002132_abnormal_respiratory_system | 1.01659531 |
104 | MP0005360_urolithiasis | 1.01582298 |
105 | MP0005195_abnormal_posterior_eye | 1.01572989 |
106 | MP0000955_abnormal_spinal_cord | 1.01236361 |
107 | MP0003633_abnormal_nervous_system | 0.99294327 |
108 | MP0001533_abnormal_skeleton_physiology | 0.99026615 |
109 | MP0010386_abnormal_urinary_bladder | 0.98753445 |
110 | MP0005085_abnormal_gallbladder_physiolo | 0.98534403 |
111 | MP0005164_abnormal_response_to | 0.98320023 |
112 | MP0004883_abnormal_blood_vessel | 0.97118785 |
113 | MP0002066_abnormal_motor_capabilities/c | 0.96795056 |
114 | MP0003937_abnormal_limbs/digits/tail_de | 0.96643661 |
115 | MP0000427_abnormal_hair_cycle | 0.96213882 |
116 | MP0002735_abnormal_chemical_nociception | 0.95270450 |
117 | MP0001879_abnormal_lymphatic_vessel | 0.94963402 |
118 | MP0000689_abnormal_spleen_morphology | 0.94925768 |
119 | MP0000647_abnormal_sebaceous_gland | 0.94864295 |
120 | MP0002405_respiratory_system_inflammati | 0.93607955 |
121 | MP0001968_abnormal_touch/_nociception | 0.93274967 |
122 | MP0005464_abnormal_platelet_physiology | 0.92906424 |
123 | MP0000604_amyloidosis | 0.92799693 |
124 | MP0005595_abnormal_vascular_smooth | 0.91772749 |
125 | MP0001348_abnormal_lacrimal_gland | 0.91023507 |
126 | MP0003045_fibrosis | 0.90511423 |
127 | MP0002166_altered_tumor_susceptibility | 0.90318032 |
128 | MP0003724_increased_susceptibility_to | 0.89613804 |
129 | MP0005397_hematopoietic_system_phenotyp | 0.89047962 |
130 | MP0001545_abnormal_hematopoietic_system | 0.89047962 |
131 | MP0004043_abnormal_pH_regulation | 0.88185817 |
132 | MP0008438_abnormal_cutaneous_collagen | 0.87841237 |
133 | MP0000579_abnormal_nail_morphology | 0.87129112 |
134 | MP0000015_abnormal_ear_pigmentation | 0.86801801 |
135 | MP0000716_abnormal_immune_system | 0.85850915 |
136 | MP0008057_abnormal_DNA_replication | 0.85373358 |
137 | MP0002398_abnormal_bone_marrow | 0.84890263 |
138 | MP0009053_abnormal_anal_canal | 0.83814167 |
139 | MP0009250_abnormal_appendicular_skeleto | 0.83196321 |
140 | MP0001324_abnormal_eye_pigmentation | 0.82511592 |
141 | MP0000631_abnormal_neuroendocrine_gland | 0.82090573 |
142 | MP0006292_abnormal_olfactory_placode | 0.82007620 |
143 | MP0009379_abnormal_foot_pigmentation | 0.80883994 |
144 | MP0001727_abnormal_embryo_implantation | 0.79814910 |
145 | MP0006072_abnormal_retinal_apoptosis | 0.79443177 |
146 | MP0002733_abnormal_thermal_nociception | 0.78349058 |
147 | MP0005379_endocrine/exocrine_gland_phen | 0.77012539 |
148 | MP0002063_abnormal_learning/memory/cond | 0.76875300 |
149 | MP0003195_calcinosis | 0.75790108 |
150 | MP0004924_abnormal_behavior | 0.75202700 |
151 | MP0005386_behavior/neurological_phenoty | 0.75202700 |
152 | MP0002938_white_spotting | 0.75183268 |
153 | MP0005253_abnormal_eye_physiology | 0.74603469 |
154 | MP0000371_diluted_coat_color | 0.74590093 |
155 | MP0003943_abnormal_hepatobiliary_system | 0.73791204 |
156 | MP0001790_abnormal_immune_system | 0.73547051 |
157 | MP0005387_immune_system_phenotype | 0.73547051 |
158 | MP0000467_abnormal_esophagus_morphology | 0.73274502 |
159 | MP0005023_abnormal_wound_healing | 0.72690231 |
160 | MP0002429_abnormal_blood_cell | 0.72641880 |
161 | MP0003941_abnormal_skin_development | 0.72582511 |
162 | MP0010094_abnormal_chromosome_stability | 0.72562656 |
163 | MP0005310_abnormal_salivary_gland | 0.71113293 |
164 | MP0002277_abnormal_respiratory_mucosa | 0.71051355 |
165 | MP0000613_abnormal_salivary_gland | 0.70840317 |
166 | MP0002653_abnormal_ependyma_morphology | 0.70785841 |
167 | MP0000343_altered_response_to | 0.69627266 |
168 | MP0010155_abnormal_intestine_physiology | 0.69285667 |
169 | MP0002928_abnormal_bile_duct | 0.69234471 |
170 | MP0005058_abnormal_lysosome_morphology | 0.69191135 |
171 | MP0002933_joint_inflammation | 0.69069180 |
172 | MP0002722_abnormal_immune_system | 0.68816204 |
173 | MP0005408_hypopigmentation | 0.67937390 |
174 | MP0004808_abnormal_hematopoietic_stem | 0.67551257 |
175 | MP0003718_maternal_effect | 0.67508979 |
176 | MP0002295_abnormal_pulmonary_circulatio | 0.67144330 |
177 | MP0002736_abnormal_nociception_after | 0.66690400 |
178 | MP0008058_abnormal_DNA_repair | 0.66202729 |
179 | MP0001119_abnormal_female_reproductive | 0.65920013 |
180 | MP0001340_abnormal_eyelid_morphology | 0.65773604 |
181 | MP0001664_abnormal_digestion | 0.65580667 |
182 | MP0009763_increased_sensitivity_to | 0.65484677 |
183 | MP0001299_abnormal_eye_distance/ | 0.64534769 |
184 | MP0005220_abnormal_exocrine_pancreas | 0.64095773 |
185 | MP0005075_abnormal_melanosome_morpholog | 0.63752916 |
186 | MP0003279_aneurysm | 0.63428085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.13261573 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.13261573 |
3 | Neurofibrillary tangles (HP:0002185) | 5.28940362 |
4 | Parakeratosis (HP:0001036) | 5.02998367 |
5 | Agnosia (HP:0010524) | 4.41536600 |
6 | Peripheral hypomyelination (HP:0007182) | 4.40856360 |
7 | Abnormality of the corticospinal tract (HP:0002492) | 4.34014833 |
8 | Sensory axonal neuropathy (HP:0003390) | 4.10911189 |
9 | Onion bulb formation (HP:0003383) | 3.96035866 |
10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.68784066 |
11 | Absent septum pellucidum (HP:0001331) | 3.66096562 |
12 | Cerebral inclusion bodies (HP:0100314) | 3.53916415 |
13 | Septo-optic dysplasia (HP:0100842) | 3.42405706 |
14 | Alacrima (HP:0000522) | 3.35501476 |
15 | Pancreatic cysts (HP:0001737) | 3.28365606 |
16 | White forelock (HP:0002211) | 3.26628519 |
17 | Patchy hypopigmentation of hair (HP:0011365) | 3.23195931 |
18 | Abnormality of the septum pellucidum (HP:0007375) | 3.17774199 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.11207914 |
20 | Optic neuritis (HP:0100653) | 3.11207914 |
21 | True hermaphroditism (HP:0010459) | 3.02472409 |
22 | Disinhibition (HP:0000734) | 2.95341706 |
23 | Spastic gait (HP:0002064) | 2.92901212 |
24 | Pancreatic fibrosis (HP:0100732) | 2.91846351 |
25 | Fibular aplasia (HP:0002990) | 2.88068661 |
26 | Slow saccadic eye movements (HP:0000514) | 2.86694967 |
27 | Retinal dysplasia (HP:0007973) | 2.85151987 |
28 | Orchitis (HP:0100796) | 2.84873911 |
29 | Cerebral hypomyelination (HP:0006808) | 2.83525670 |
30 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.82848167 |
31 | Abnormal auditory evoked potentials (HP:0006958) | 2.80259487 |
32 | Prolonged neonatal jaundice (HP:0006579) | 2.76010407 |
33 | Colon cancer (HP:0003003) | 2.73164145 |
34 | Hypoplasia of the uterus (HP:0000013) | 2.72173614 |
35 | Recurrent bacterial skin infections (HP:0005406) | 2.71681979 |
36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70844165 |
37 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.70093825 |
38 | Hypoplasia of the fovea (HP:0007750) | 2.70093825 |
39 | Supranuclear gaze palsy (HP:0000605) | 2.68877707 |
40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.68641940 |
41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.61830916 |
42 | Partial duplication of thumb phalanx (HP:0009944) | 2.61732979 |
43 | Chronic hepatic failure (HP:0100626) | 2.61631550 |
44 | Fibular hypoplasia (HP:0003038) | 2.59768311 |
45 | Anteriorly placed anus (HP:0001545) | 2.59187874 |
46 | Decreased lacrimation (HP:0000633) | 2.59086503 |
47 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.58267934 |
48 | Amyotrophic lateral sclerosis (HP:0007354) | 2.58111604 |
49 | Dysmetria (HP:0001310) | 2.55605756 |
50 | Hematochezia (HP:0002573) | 2.54191240 |
51 | Hypophosphatemic rickets (HP:0004912) | 2.50784558 |
52 | Absent/shortened dynein arms (HP:0200106) | 2.49876122 |
53 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.49876122 |
54 | Chin dimple (HP:0010751) | 2.49743566 |
55 | Decreased central vision (HP:0007663) | 2.49373582 |
56 | Hypoplasia of the iris (HP:0007676) | 2.45692151 |
57 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.45254975 |
58 | Metabolic alkalosis (HP:0200114) | 2.43292466 |
59 | Increased IgM level (HP:0003496) | 2.43143127 |
60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42039968 |
61 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.39477140 |
62 | Abnormality of midbrain morphology (HP:0002418) | 2.39394537 |
63 | Molar tooth sign on MRI (HP:0002419) | 2.39394537 |
64 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.39150718 |
65 | Hepatosplenomegaly (HP:0001433) | 2.38680658 |
66 | Myositis (HP:0100614) | 2.38150056 |
67 | Abnormality of the fovea (HP:0000493) | 2.37954908 |
68 | Leukodystrophy (HP:0002415) | 2.37905603 |
69 | Thickened helices (HP:0000391) | 2.37293584 |
70 | Termporal pattern (HP:0011008) | 2.36221299 |
71 | Insidious onset (HP:0003587) | 2.36221299 |
72 | Asymmetry of the thorax (HP:0001555) | 2.33968210 |
73 | Hypomagnesemia (HP:0002917) | 2.33698003 |
74 | Cupped ear (HP:0000378) | 2.33125237 |
75 | Disproportionate short-trunk short stature (HP:0003521) | 2.32965258 |
76 | Partial agenesis of the corpus callosum (HP:0001338) | 2.31539107 |
77 | Conical tooth (HP:0000698) | 2.29981820 |
78 | Morphological abnormality of the inner ear (HP:0011390) | 2.29976802 |
79 | Scanning speech (HP:0002168) | 2.29289130 |
80 | Bile duct proliferation (HP:0001408) | 2.29052582 |
81 | Abnormal biliary tract physiology (HP:0012439) | 2.29052582 |
82 | Spastic paraparesis (HP:0002313) | 2.26765498 |
83 | Intention tremor (HP:0002080) | 2.26037222 |
84 | Prostate neoplasm (HP:0100787) | 2.25194711 |
85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.25007360 |
86 | Poor head control (HP:0002421) | 2.23184547 |
87 | Hypoplastic pelvis (HP:0008839) | 2.22711271 |
88 | Encephalitis (HP:0002383) | 2.22158872 |
89 | Premature skin wrinkling (HP:0100678) | 2.20795653 |
90 | Attenuation of retinal blood vessels (HP:0007843) | 2.19004240 |
91 | Recurrent abscess formation (HP:0002722) | 2.16332226 |
92 | Partial duplication of the phalanx of hand (HP:0009999) | 2.16238961 |
93 | Ankle clonus (HP:0011448) | 2.16000607 |
94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14841770 |
95 | Nasolacrimal duct obstruction (HP:0000579) | 2.14091507 |
96 | Duplicated collecting system (HP:0000081) | 2.09069326 |
97 | Autoamputation (HP:0001218) | 2.07938250 |
98 | Clumsiness (HP:0002312) | 2.07701150 |
99 | Keratoconjunctivitis (HP:0001096) | 2.07433443 |
100 | Methylmalonic acidemia (HP:0002912) | 2.07285787 |
101 | Humeroradial synostosis (HP:0003041) | 2.07072275 |
102 | Synostosis involving the elbow (HP:0003938) | 2.07072275 |
103 | Abnormality of T cell number (HP:0011839) | 2.05869615 |
104 | Hemoptysis (HP:0002105) | 2.05556484 |
105 | Chronic sinusitis (HP:0011109) | 2.04964143 |
106 | Akinesia (HP:0002304) | 2.03670747 |
107 | Keratoconjunctivitis sicca (HP:0001097) | 2.03568516 |
108 | Increased circulating renin level (HP:0000848) | 2.03429607 |
109 | Stomach cancer (HP:0012126) | 2.02882048 |
110 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01791342 |
111 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01791342 |
112 | Stridor (HP:0010307) | 2.01710090 |
113 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97937274 |
114 | Aortic aneurysm (HP:0004942) | 1.97428943 |
115 | Mixed hearing impairment (HP:0000410) | 1.96729938 |
116 | Esophageal atresia (HP:0002032) | 1.96553146 |
117 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.95692092 |
118 | Pulmonary infiltrates (HP:0002113) | 1.94064915 |
119 | Split foot (HP:0001839) | 1.93737639 |
120 | Overfolded helix (HP:0000396) | 1.93021225 |
121 | Erythroderma (HP:0001019) | 1.92042203 |
122 | Anomalous pulmonary venous return (HP:0010772) | 1.91960733 |
123 | Capillary hemangiomas (HP:0005306) | 1.91790560 |
124 | Aplasia involving bones of the extremities (HP:0009825) | 1.90759012 |
125 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.90759012 |
126 | Aplasia of the phalanges of the hand (HP:0009802) | 1.90759012 |
127 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90200377 |
128 | Hypochromic microcytic anemia (HP:0004840) | 1.89851922 |
129 | Albinism (HP:0001022) | 1.89832211 |
130 | Peritonitis (HP:0002586) | 1.89800523 |
131 | Abnormality of glycolysis (HP:0004366) | 1.89776071 |
132 | Increased serum pyruvate (HP:0003542) | 1.89776071 |
133 | Panhypogammaglobulinemia (HP:0003139) | 1.87844400 |
134 | Duplication of thumb phalanx (HP:0009942) | 1.86382783 |
135 | Recurrent skin infections (HP:0001581) | 1.85837606 |
136 | Fused cervical vertebrae (HP:0002949) | 1.84648679 |
137 | Congenital hepatic fibrosis (HP:0002612) | 1.84577076 |
138 | Asplenia (HP:0001746) | 1.84340718 |
139 | Abnormal ciliary motility (HP:0012262) | 1.84150279 |
140 | Abnormality of chromosome stability (HP:0003220) | 1.84025026 |
141 | Hypokalemic alkalosis (HP:0001949) | 1.83754801 |
142 | Bifid tongue (HP:0010297) | 1.82814303 |
143 | Cerebral hemorrhage (HP:0001342) | 1.81547437 |
144 | Cystic liver disease (HP:0006706) | 1.81181078 |
145 | CNS hypomyelination (HP:0003429) | 1.80048243 |
146 | Nephronophthisis (HP:0000090) | 1.79925805 |
147 | Abnormally folded helix (HP:0008544) | 1.79449902 |
148 | Bilateral microphthalmos (HP:0007633) | 1.78952235 |
149 | Abolished electroretinogram (ERG) (HP:0000550) | 1.78371227 |
150 | Broad ribs (HP:0000885) | 1.78305663 |
151 | Abnormality of B cell number (HP:0010975) | 1.78220651 |
152 | Inappropriate behavior (HP:0000719) | 1.78070340 |
153 | Neoplasm of the adrenal cortex (HP:0100641) | 1.77854725 |
154 | Decreased motor nerve conduction velocity (HP:0003431) | 1.77682148 |
155 | T lymphocytopenia (HP:0005403) | 1.77491885 |
156 | Abnormality of the pulmonary veins (HP:0011718) | 1.75740460 |
157 | Vasculitis (HP:0002633) | 1.75693081 |
158 | Renal Fanconi syndrome (HP:0001994) | 1.75201737 |
159 | Foot dorsiflexor weakness (HP:0009027) | 1.75160938 |
160 | Recurrent fungal infections (HP:0002841) | 1.74454366 |
161 | Aplasia cutis congenita (HP:0001057) | 1.73883581 |
162 | Myokymia (HP:0002411) | 1.72799295 |
163 | Xerostomia (HP:0000217) | 1.72326933 |
164 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.71786458 |
165 | Upper motor neuron abnormality (HP:0002127) | 1.71578868 |
166 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71287152 |
167 | Increased corneal curvature (HP:0100692) | 1.71065910 |
168 | Keratoconus (HP:0000563) | 1.71065910 |
169 | Axonal loss (HP:0003447) | 1.70973704 |
170 | Abnormality of the renal medulla (HP:0100957) | 1.69961382 |
171 | 3-Methylglutaconic aciduria (HP:0003535) | 1.69906024 |
172 | Porencephaly (HP:0002132) | 1.69524939 |
173 | Stomatitis (HP:0010280) | 1.69232543 |
174 | Optic nerve hypoplasia (HP:0000609) | 1.69084608 |
175 | Hypoproteinemia (HP:0003075) | 1.69007485 |
176 | Abnormality of T cells (HP:0002843) | 1.68934139 |
177 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68403810 |
178 | Abnormality of the renal collecting system (HP:0004742) | 1.68115484 |
179 | Chronic otitis media (HP:0000389) | 1.68071044 |
180 | Recurrent viral infections (HP:0004429) | 1.67662490 |
181 | Paraparesis (HP:0002385) | 1.67478578 |
182 | Poor speech (HP:0002465) | 1.67453960 |
183 | Abnormality of magnesium homeostasis (HP:0004921) | 1.66683869 |
184 | Bowel incontinence (HP:0002607) | 1.66137620 |
185 | Abnormality of T cell physiology (HP:0011840) | 1.66129441 |
186 | Choroideremia (HP:0001139) | 1.65935816 |
187 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.65623198 |
188 | Agammaglobulinemia (HP:0004432) | 1.65274151 |
189 | Recurrent bronchitis (HP:0002837) | 1.64569352 |
190 | Anal atresia (HP:0002023) | 1.64241240 |
191 | Anencephaly (HP:0002323) | 1.63176634 |
192 | Amaurosis fugax (HP:0100576) | 1.63012099 |
193 | Intrahepatic cholestasis (HP:0001406) | 1.62616539 |
194 | Vacuolated lymphocytes (HP:0001922) | 1.61583451 |
195 | Natal tooth (HP:0000695) | 1.61019101 |
196 | Leukocytosis (HP:0001974) | 1.60649148 |
197 | Meckel diverticulum (HP:0002245) | 1.60492206 |
198 | Abnormality of the prostate (HP:0008775) | 1.60187206 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.69986843 |
2 | NUAK1 | 3.91786276 |
3 | OXSR1 | 3.79602944 |
4 | PKN1 | 3.20345802 |
5 | TAF1 | 2.96619574 |
6 | EPHB1 | 2.94936067 |
7 | BLK | 2.85122872 |
8 | TIE1 | 2.79487986 |
9 | EIF2AK1 | 2.77374506 |
10 | ZAK | 2.73415134 |
11 | VRK2 | 2.70450844 |
12 | FRK | 2.60239059 |
13 | CASK | 2.53097683 |
14 | MAP4K2 | 2.35434719 |
15 | MAPKAPK5 | 2.33180885 |
16 | PBK | 2.22902093 |
17 | WNK4 | 2.18672984 |
18 | TNIK | 2.17477913 |
19 | EIF2AK3 | 2.13238846 |
20 | TRIM28 | 2.13124479 |
21 | BCR | 2.11801369 |
22 | ACVR1B | 1.95017003 |
23 | PNCK | 1.81668341 |
24 | CLK1 | 1.81003391 |
25 | WNK1 | 1.79934046 |
26 | TYK2 | 1.78604639 |
27 | MAP3K13 | 1.78456966 |
28 | CDK19 | 1.69518318 |
29 | CSNK1A1L | 1.67856447 |
30 | STK10 | 1.66385847 |
31 | CSNK1G3 | 1.63470659 |
32 | FGR | 1.62096056 |
33 | KIT | 1.55134290 |
34 | BRSK2 | 1.53907232 |
35 | NEK6 | 1.50621247 |
36 | FGFR2 | 1.49917884 |
37 | LIMK1 | 1.49276594 |
38 | JAK3 | 1.48518443 |
39 | TGFBR2 | 1.44015938 |
40 | TEC | 1.43431790 |
41 | MET | 1.40473478 |
42 | MUSK | 1.40233156 |
43 | UHMK1 | 1.39046885 |
44 | CAMK2B | 1.37928520 |
45 | CSNK1G1 | 1.37527621 |
46 | MST4 | 1.37309401 |
47 | FLT3 | 1.33788537 |
48 | TESK2 | 1.32946291 |
49 | ROCK2 | 1.31261060 |
50 | PLK3 | 1.29934489 |
51 | MELK | 1.29078074 |
52 | SIK3 | 1.26048027 |
53 | PRKG2 | 1.25929966 |
54 | TGFBR1 | 1.25828917 |
55 | IKBKE | 1.25351392 |
56 | NLK | 1.24149441 |
57 | BMPR1B | 1.20677451 |
58 | ADRBK2 | 1.20365701 |
59 | BCKDK | 1.20333372 |
60 | JAK1 | 1.18675476 |
61 | PTK2B | 1.17441831 |
62 | GRK1 | 1.14700670 |
63 | PRPF4B | 1.14425330 |
64 | CSNK1G2 | 1.12146775 |
65 | VRK1 | 1.06748392 |
66 | CAMK2D | 1.05644200 |
67 | MKNK1 | 1.05480724 |
68 | PRKCQ | 1.05448478 |
69 | IKBKB | 1.05432574 |
70 | TAOK3 | 1.04767313 |
71 | EIF2AK2 | 1.02726559 |
72 | FER | 1.02088278 |
73 | WNK3 | 1.01088532 |
74 | MAPK15 | 0.99992881 |
75 | NTRK1 | 0.99467466 |
76 | MKNK2 | 0.99082777 |
77 | PLK2 | 0.96775687 |
78 | FES | 0.95495001 |
79 | STK3 | 0.95211626 |
80 | GRK7 | 0.92599065 |
81 | AKT3 | 0.92171885 |
82 | IRAK2 | 0.92124199 |
83 | MARK2 | 0.91602585 |
84 | DYRK2 | 0.90655815 |
85 | PIK3CG | 0.89750158 |
86 | PLK4 | 0.88249403 |
87 | EPHA4 | 0.88161069 |
88 | MATK | 0.87239425 |
89 | MAP3K14 | 0.83452752 |
90 | SYK | 0.82969308 |
91 | ERBB3 | 0.82957664 |
92 | CAMK2G | 0.81280324 |
93 | CAMK2A | 0.78418467 |
94 | IRAK1 | 0.76533789 |
95 | PIK3CA | 0.74950963 |
96 | TRPM7 | 0.72886013 |
97 | PRKCE | 0.71880353 |
98 | PAK6 | 0.71124544 |
99 | NEK9 | 0.70293223 |
100 | STK16 | 0.69032000 |
101 | SGK494 | 0.68366905 |
102 | SGK223 | 0.68366905 |
103 | GRK5 | 0.68150517 |
104 | PRKD1 | 0.66730128 |
105 | CAMK1G | 0.66640809 |
106 | FYN | 0.63698244 |
107 | RPS6KA5 | 0.63407322 |
108 | KDR | 0.62957340 |
109 | MARK1 | 0.62705518 |
110 | ADRBK1 | 0.62442023 |
111 | IRAK4 | 0.59880111 |
112 | ITK | 0.59530908 |
113 | CDK5 | 0.54814341 |
114 | HCK | 0.54196232 |
115 | LCK | 0.54173552 |
116 | EPHB2 | 0.53882598 |
117 | IGF1R | 0.53711089 |
118 | HIPK2 | 0.53294469 |
119 | CSK | 0.52183740 |
120 | PRKG1 | 0.51986324 |
121 | MAPK13 | 0.51456925 |
122 | BUB1 | 0.50108428 |
123 | PDPK1 | 0.48407126 |
124 | INSRR | 0.47978388 |
125 | BMPR2 | 0.47596966 |
126 | CDK9 | 0.47393049 |
127 | BTK | 0.46755742 |
128 | TBK1 | 0.45875294 |
129 | SRPK1 | 0.45730819 |
130 | PAK3 | 0.45256994 |
131 | FGFR1 | 0.45138505 |
132 | TXK | 0.44959116 |
133 | PHKG1 | 0.43661922 |
134 | PHKG2 | 0.43661922 |
135 | CDK14 | 0.43565978 |
136 | MAP4K1 | 0.43014856 |
137 | CSNK1D | 0.42833052 |
138 | NEK1 | 0.42562334 |
139 | WEE1 | 0.41842001 |
140 | ABL1 | 0.41399973 |
141 | STK38L | 0.40770206 |
142 | CSF1R | 0.40651030 |
143 | MAP2K2 | 0.40245332 |
144 | MARK3 | 0.39259235 |
145 | CDK3 | 0.38165583 |
146 | CDK15 | 0.37848190 |
147 | CSNK1A1 | 0.37685133 |
148 | ERBB4 | 0.37428676 |
149 | CDK11A | 0.37412117 |
150 | TLK1 | 0.36524870 |
151 | NEK2 | 0.35566420 |
152 | GSK3A | 0.35025393 |
153 | MAP3K8 | 0.34792445 |
154 | MAPK7 | 0.34725923 |
155 | ICK | 0.34400338 |
156 | INSR | 0.34293697 |
157 | YES1 | 0.33938271 |
158 | TYRO3 | 0.33867607 |
159 | CDK18 | 0.32880843 |
160 | LYN | 0.32776617 |
161 | DYRK1A | 0.31920564 |
162 | EPHA3 | 0.31460571 |
163 | STK11 | 0.30830453 |
164 | ARAF | 0.30691561 |
165 | PRKACA | 0.29859795 |
166 | PRKACB | 0.29811199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.21998176 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.10889111 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.04040041 |
4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.09780309 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.04855756 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.79056684 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08278337 |
8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.01643889 |
9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00364601 |
10 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97130658 |
11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95703074 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87221818 |
13 | Protein export_Homo sapiens_hsa03060 | 1.83619185 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80173921 |
15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.79260508 |
16 | Proteasome_Homo sapiens_hsa03050 | 1.78020726 |
17 | Axon guidance_Homo sapiens_hsa04360 | 1.77040828 |
18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.64580891 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.63873593 |
20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.63685063 |
21 | Measles_Homo sapiens_hsa05162 | 1.59988131 |
22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54458890 |
23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53741476 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.47617213 |
25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47460462 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44516990 |
27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39822545 |
28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39774096 |
29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39519910 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38445888 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38257300 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.37592104 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36740449 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35508043 |
35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35107821 |
36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31495248 |
37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28857651 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28210440 |
39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26701710 |
40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26609600 |
41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23719772 |
42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23411139 |
43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.20720928 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.19205208 |
45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17441870 |
46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15252284 |
47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14344777 |
48 | Morphine addiction_Homo sapiens_hsa05032 | 1.13237926 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.08828004 |
50 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08764103 |
51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06549959 |
52 | RNA degradation_Homo sapiens_hsa03018 | 1.06443536 |
53 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.05313206 |
54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03963556 |
55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01964477 |
56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01600350 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01232142 |
58 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01150265 |
59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95496640 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94302328 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94294107 |
62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93978550 |
63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91745919 |
64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91608697 |
65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90220193 |
66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88221604 |
67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87937502 |
68 | Long-term depression_Homo sapiens_hsa04730 | 0.87736228 |
69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87148167 |
70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.87016411 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86918121 |
72 | Tuberculosis_Homo sapiens_hsa05152 | 0.84589194 |
73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84011049 |
74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83573354 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81369162 |
76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79911546 |
77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79747482 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79092894 |
79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78422218 |
80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77818780 |
81 | Hepatitis C_Homo sapiens_hsa05160 | 0.77741981 |
82 | Malaria_Homo sapiens_hsa05144 | 0.77680115 |
83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77022721 |
84 | Allograft rejection_Homo sapiens_hsa05330 | 0.76237678 |
85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75756652 |
86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74620448 |
87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73697240 |
88 | Asthma_Homo sapiens_hsa05310 | 0.73102652 |
89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72417497 |
90 | RNA polymerase_Homo sapiens_hsa03020 | 0.72371223 |
91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71056874 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70806206 |
93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68911609 |
94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68867189 |
95 | Mismatch repair_Homo sapiens_hsa03430 | 0.68860970 |
96 | Salivary secretion_Homo sapiens_hsa04970 | 0.67893219 |
97 | Peroxisome_Homo sapiens_hsa04146 | 0.67486970 |
98 | Taste transduction_Homo sapiens_hsa04742 | 0.67033374 |
99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65934011 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.65581271 |
101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65036930 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64230089 |
103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61798839 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61207290 |
105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61158726 |
106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61131707 |
107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60500384 |
108 | Phagosome_Homo sapiens_hsa04145 | 0.58849469 |
109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58718275 |
110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57091376 |
111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56391888 |
112 | Tight junction_Homo sapiens_hsa04530 | 0.56228597 |
113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55626536 |
114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55509053 |
115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53618648 |
116 | Pertussis_Homo sapiens_hsa05133 | 0.52916205 |
117 | RNA transport_Homo sapiens_hsa03013 | 0.51706379 |
118 | Lysosome_Homo sapiens_hsa04142 | 0.51328322 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50314903 |
120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50168678 |
121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49127061 |
122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48990879 |
123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48311552 |
124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47624371 |
125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47446174 |
126 | Hepatitis B_Homo sapiens_hsa05161 | 0.46898917 |
127 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45727683 |
128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45620093 |
129 | ABC transporters_Homo sapiens_hsa02010 | 0.45406177 |
130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45389816 |
131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45092376 |
132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45008622 |
133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44985872 |
134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44913018 |
135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44361213 |
136 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43469040 |
137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42957527 |
138 | Endocytosis_Homo sapiens_hsa04144 | 0.42329792 |
139 | Renin secretion_Homo sapiens_hsa04924 | 0.41890661 |
140 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41470031 |
141 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39992014 |
142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38936410 |
143 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38831553 |
144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38580763 |
145 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37999936 |
146 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37957081 |
147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37884675 |
148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37490883 |
149 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36073315 |
150 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35556491 |
151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34639783 |
152 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34416554 |
153 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34170090 |
154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33985380 |
155 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32976412 |
156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32666116 |